Fortis Healthcare announced its unaudited financial results for the second quarter and half-year ended September 30, 2026. The company reported consolidated revenues of INR 2,735 Crore for Q2 FY27, marking a significant 17.3% increase year-on-year. The consolidated Profit After Tax stood at INR 320 Crore, with a PAT margin of 11.7%. The hospital business also saw robust growth, with revenues up 18.6%.
Fortis Healthcare Announces Q2 FY27 Financial Results
Fortis Healthcare Limited has announced its unaudited consolidated financial results for the quarter and half year ended September 30, 2026. The company reported a strong performance, with consolidated revenues for the second quarter of FY27 reaching INR 2,735 Crore, an increase of 17.3% compared to Q2 FY26. The Profit After Tax for the quarter was INR 320 Crore, resulting in a Profit After Tax Margin of 11.7%.
Segment Performance Highlights
The Hospital Business contributed significantly to the overall growth, with revenues rising by 18.6% to INR 2,340 Crore in Q2 FY27. The PAT Margin for this segment was 12.1%. The Diagnostics Business also demonstrated positive momentum, with gross revenues up by 12.2% to INR 448 Crore. The PAT Margin for diagnostics improved to 15.2%.
Half-Yearly Financials
For the half year ended September 30, 2026, Fortis Healthcare reported consolidated revenues of INR 5,280 Crore, an increase of 17.4% year-on-year. The consolidated Profit After Tax for H1 FY27 stood at INR 593 Crore, with a PAT Margin of 11.2%. The Hospital Business saw revenues grow by 18.8% to INR 4,527 Crore, while the Diagnostics Business revenues increased by 11.2% to INR 855 Crore.
Balance Sheet and Key Ratios
As of September 30, 2026, the company’s net debt stood at INR 2,188 Crore, with a Net Debt to EBITDA ratio of 0.87x. The Net debt to equity ratio was reported at 0.20x.
Strategic Initiatives
The company highlighted several strategic initiatives, including the acquisition of Suguna Hospital in Bengaluru and a long-term healthcare services agreement for a new hospital in Ashok Vihar, New Delhi. These moves are aimed at strengthening its presence in key markets and driving network synergies.
Source: BSE
